Founded in 1998, CLS has established itself as an independent and privately owned cell bank that now includes over 800 cell lines from a variety of tumors, tissues and species. This impressive collection makes CLS one of the largest and most important independent cell banks in the world.
In addition to providing authenticated cell cultures, CLS excels in the production of cell products such as DNA, RNA and cell pellets. In addition, our company provides industry-leading services such as large-scale cell culture production, mycoplasma and virus testing for research institutions and industry partners.
CLS strives to shape the future of biomedical research by pushing the boundaries of knowledge and developing innovative technologies. We are committed to helping the scientific community make breakthrough discoveries and develop new therapeutic approaches to improve the lives of people around the world.
Our mission statement at CLS is to preserve the valuable legacy of current research and to provide future generations of scientists with the opportunity to build on this foundation. We recognize our responsibility to the scientific community and society and continually strive for excellence in quality, innovation, and collaboration. In doing so, we always focus on the integrity, transparency and sustainability of our work and products.